Randomised Phase II Feasibility Trial of Image-guided External Beam Radiotherapy With or Without High Dose Rate Brachytherapy Boost in Men with Intermediate-risk Prostate Cancer (CCTG PR15/ NCT01982786).
Clin Oncol (R Coll Radiol). 2018 Jun 11;:
Magnetic Resonance Imaging-guided Brachytherapy Re-irradiation for Isolated Local Recurrence of Soft Tissue Sarcoma.
Cureus. 2018 Apr 10;10(4):e2457
J Clin Oncol. 2018 Jun 07;:JCO2018787325
BJU Int. 2018 May 03;:
Med Dosim. 2018 Apr 11;:
Improving patient journey and quality of care: Summary from the 2nd Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting.
Can Urol Assoc J. 2018 Mar 19;:
The Bladder Utility Symptom Scale (BUSS): A Novel Patient-Reported Outcome Instrument in Bladder Cancer.
J Urol. 2018 Mar 09;:
Serum miRNA predicts viable disease post-chemotherapy in testicular non-seminoma germ cell tumor patients.
J Urol. 2018 Feb 20;:
A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma.
Eur Urol Focus. 2018 Feb 07;:
Recommendations for followup of stage I and II seminoma: The Princess Margaret Cancer Centre approach.
Can Urol Assoc J. 2017 Dec 01;: